Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Novartis Habitrol Approval Marks First 3-In-1 Smoking Cessation Kit

This article was originally published in The Tan Sheet

Executive Summary

Novartis Consumer Healthcare's Habitrol multi-dose smoking cessation kit will represent the first time an entire course of nicotine replacement therapy is available in a single package

You may also be interested in...



Habitrol labeling changes

FDA approves supplemental NDA 20-076/S-021 for labeling changes to Novartis' Habitrol smoking cessation patch on July 15. New packaging will incorporate current pregnancy/breastfeeding warning, as requested by FDA in 2001 (1"The Tan Sheet" August 27, 2001, p. 3). Changes will appear on "Drug Facts" box of 7 mg, 14 mg and 21 mg Habitrol cartons. Revised labeling also will be reflected on multi-dose Habitrol kit, which was approved as the first 3-in-1 smoking cessation offering in July (2"The Tan Sheet" July 22, 2002, p. 4)...

Habitrol labeling changes

FDA approves supplemental NDA 20-076/S-021 for labeling changes to Novartis' Habitrol smoking cessation patch on July 15. New packaging will incorporate current pregnancy/breastfeeding warning, as requested by FDA in 2001 (1"The Tan Sheet" August 27, 2001, p. 3). Changes will appear on "Drug Facts" box of 7 mg, 14 mg and 21 mg Habitrol cartons. Revised labeling also will be reflected on multi-dose Habitrol kit, which was approved as the first 3-in-1 smoking cessation offering in July (2"The Tan Sheet" July 22, 2002, p. 4)...

Habitrol labeling changes

FDA approves supplemental NDA 20-076/S-021 for labeling changes to Novartis' Habitrol smoking cessation patch on July 15. New packaging will incorporate current pregnancy/breastfeeding warning, as requested by FDA in 2001 (1"The Tan Sheet" August 27, 2001, p. 3). Changes will appear on "Drug Facts" box of 7 mg, 14 mg and 21 mg Habitrol cartons. Revised labeling also will be reflected on multi-dose Habitrol kit, which was approved as the first 3-in-1 smoking cessation offering in July (2"The Tan Sheet" July 22, 2002, p. 4)...

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS094302

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel